American Capital Management Inc. Increases Holdings in Dolby Laboratories, Inc. (DLB)

American Capital Management Inc. raised its position in Dolby Laboratories, Inc. (NYSE:DLB) by 1.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 110,541 shares of the electronics maker’s stock after acquiring an additional 1,095 shares during the period. American Capital Management Inc. owned approximately 0.11% of Dolby Laboratories worth $7,735,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp grew its stake in Dolby Laboratories by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 381,272 shares of the electronics maker’s stock valued at $23,521,000 after acquiring an additional 1,841 shares during the period. Strs Ohio acquired a new stake in Dolby Laboratories in the second quarter valued at approximately $496,000. Sawtooth Solutions LLC acquired a new stake in Dolby Laboratories in the second quarter valued at approximately $396,000. Public Employees Retirement System of Ohio grew its stake in Dolby Laboratories by 49.9% in the second quarter. Public Employees Retirement System of Ohio now owns 209,156 shares of the electronics maker’s stock valued at $12,903,000 after acquiring an additional 69,610 shares during the period. Finally, Schwab Charles Investment Management Inc. grew its stake in Dolby Laboratories by 11.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 430,636 shares of the electronics maker’s stock valued at $26,566,000 after acquiring an additional 42,911 shares during the period. 56.24% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have recently weighed in on DLB shares. B. Riley dropped their target price on Dolby Laboratories from $69.00 to $63.00 and set a “neutral” rating on the stock in a report on Thursday, October 25th. R. F. Lafferty dropped their target price on Dolby Laboratories from $81.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, October 22nd. Tigress Financial restated a “buy” rating on shares of Dolby Laboratories in a report on Friday, September 7th. Barrington Research restated a “buy” rating and issued a $78.00 target price on shares of Dolby Laboratories in a report on Thursday, July 26th. Finally, ValuEngine upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Friday, July 20th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $72.80.

In related news, insider Kevin J. Yeaman sold 30,000 shares of Dolby Laboratories stock in a transaction on Thursday, August 23rd. The stock was sold at an average price of $70.00, for a total transaction of $2,100,000.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Dagmar Dolby sold 22,642 shares of Dolby Laboratories stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $70.07, for a total value of $1,586,524.94. The disclosure for this sale can be found here. Insiders sold 87,976 shares of company stock worth $6,082,895 in the last 90 days. Corporate insiders own 43.80% of the company’s stock.

DLB stock opened at $68.85 on Monday. Dolby Laboratories, Inc. has a twelve month low of $58.35 and a twelve month high of $74.29. The company has a market capitalization of $7.14 billion, a PE ratio of 26.89, a P/E/G ratio of 2.34 and a beta of 0.73.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Wednesday, October 24th. The electronics maker reported $0.47 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.17. Dolby Laboratories had a return on equity of 12.81% and a net margin of 10.43%. The company had revenue of $265.33 million for the quarter, compared to analyst estimates of $272.42 million. During the same quarter last year, the company earned $0.21 earnings per share. On average, sell-side analysts forecast that Dolby Laboratories, Inc. will post 2.45 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 14th. Stockholders of record on Monday, November 5th will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date is Friday, November 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.16. Dolby Laboratories’s dividend payout ratio (DPR) is currently 26.67%.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

See Also: Stock Ratings and Recommendations: Understanding Analyst Upgrades and Downgrades

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply